SOPHiA GENETICS to Participate in Upcoming November Investor Conferences
October 28 2021 - 4:05PM
SOPHiA GENETICS SA (Nasdaq: SOPH) today announced the company will
be participating virtually in the following investor conferences:
- Credit Suisse 30th Annual Healthcare Conference; Fireside Chat
on Thursday, November 11th at 2:40pm ET / 8:40pm CET
- Piper Sandler 33rd Annual Healthcare Conference; Presentation
available on demand beginning November 22nd at 10:00am ET / 4:00pm
CET
- Evercore ISI HealthCONx Conference; Fireside Chat on Tuesday,
November 30th at 8:00am ET / 2:00pm CET
Interested parties may access live and archived webcasts of the
presentations on the “Investors” section of the company website at
ir.sophiagenetics.com.
About SOPHiA GENETICSSOPHiA GENETICS (Nasdaq:
SOPH) is a healthcare technology company dedicated to establishing
the practice of data-driven medicine as the standard of care and
for life sciences research. It is the creator of the SOPHiA DDM™
Platform, a cloud-based SaaS platform capable of analyzing data and
generating insights from complex multimodal data sets and different
diagnostic modalities. The SOPHiA DDM™ Platform and related
solutions, products and services are currently used by more than
780 hospital, laboratory, and biopharma institutions globally.
Media Contact:Eliza
Bamontiebamonti@sophiagenetics.com
Investor Contact:ir@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From May 2024 to Jun 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jun 2023 to Jun 2024